Ispire Technology reported a sequential recovery in gross margin and Adjusted EBITDA during the first quarter of fiscal 2027, while revenue declined year on year and cash balances fell from the previous fiscal year-end.
Ispire Technology Inc. (Nasdaq:ISPR) reported a sequential improvement in gross margin, net loss and Adjusted EBITDA for the first quarter of fiscal 2027, although revenue declined from the year-ago period and the company ended the quarter with lower cash and working capital than at the previous fiscal year-end.
For the three months ended September 30, 2026, revenue was $27.5 million. That was down 9.3% from $30.4 million in the first quarter of fiscal year 2026. Ispire said the decrease was primarily linked to lower European sales amid what it described as an increasingly restrictive regulatory environment for vaping products.
Revenue increased 3.2% from $26.7 million in the fourth quarter of fiscal 2026.
Gross profit was $4.5 million, compared with $5.1 million in the year-ago quarter. Gross margin was 16.2%, versus 17.0% in the first quarter of fiscal year 2026 and 6.3% in the preceding quarter.
The company attributed the sequential improvement to the one-time inventory impairment and returns charges recorded in the fourth quarter of fiscal 2026.
Ispire reported a GAAP net loss of $6.4 million, or ($0.11) per share, compared with a net loss of $3.3 million, or ($0.06) per share, in the year-ago period. The current-quarter result included $4.8 million of credit loss expense.
Total operating expenses were $10.6 million, up from $7.8 million in the first quarter of fiscal year 2026. The company said the increase was driven primarily by non-cash credit loss expenses. Credit loss expense was $4.8 million, compared with $1.8 million in the year-ago quarter.
Adjusted EBITDA, a non-GAAP measure, was $136,000 for the quarter. This compared with $0.6 million in the first quarter of fiscal 2026 and an Adjusted EBITDA loss of ($2.3) million in the previous quarter.
Ispire said the sequential improvement reflected the recovery in gross margin. The company cautions that Adjusted EBITDA should not be viewed as a substitute for results prepared under U.S. GAAP and may not be comparable with similarly named measures used by other companies.
At September 30, 2026, Ispire held cash of $15.6 million and working capital of $0.4 million. Compared with the fiscal year ended June 30, 2026, cash decreased by $3.7 million and working capital decreased by $0.4 million.
The company said net accounts receivable had fallen by approximately 80% from peak levels in fiscal 2025. It attributed the reduction to collections, allowances for credit losses against outstanding balances, and changes to customer credit standards and payment terms.
Ispire said it is investing in its Malaysia manufacturing facility during fiscal year 2027 while pursuing additional original equipment manufacture and original design manufacture relationships. The company also identified its Vapor OEM and ODM pipeline, G-Mesh technology, IKE Tech's age-gating platform and its nicotine pouch joint venture with Jincheng Pharma as areas being advanced.
Management said it believes the company is close to securing a significant OEM and ODM relationship with a well-known regional brand in Southeast Asia. The relationship has not been stated as secured; Ispire said it hopes to provide an update in the coming months.
Ispire also said IKE Tech is advancing commercialisation efforts that include a planned U.S. pilot of its IKE 2.0 age-gating platform with Charlie's Holdings. The company said it remains focused on achieving cash-flow-positive performance, while management expects cash flow to improve as new manufacturing and commercial programmes begin to scale. Its forward-looking disclosures state that the timing of positive cash flow remains uncertain and may occur, if at all.
Ispire researches, develops, designs, commercialises, sells, markets and distributes branded e-cigarettes and cannabis vaping products. Its e-cigarette products are marketed under the Aspire name, while its cannabis products are marketed under the Ispire brand, primarily through original design manufacture relationships.
Ispire Technology Inc. reported financial results for the first fiscal quarter ended September 30, 2026. The company highlighted sequential improvements in revenue, gross margin, GAAP net loss and Adjusted EBITDA, while also reporting a year-on-year revenue decline and lower cash.
Ispire Technology Inc. researches, develops, designs, commercialises, sells, markets and distributes branded e-cigarettes and cannabis vaping products. Its branded e-cigarettes are marketed under the Aspire name, while its cannabis products are marketed under the Ispire brand, primarily on an original design manufacture basis.
Ispire Technology Inc. is listed on Nasdaq under the ticker symbol ISPR, written in the source as Nasdaq:ISPR.
Ispire Technology Inc. reported revenue of $27.5 million for the three months ended September 30, 2026. Revenue decreased 9.3% from $30.4 million in the first quarter of fiscal year 2026, but increased 3.2% sequentially from $26.7 million in the fourth quarter of fiscal 2026.
Ispire Technology Inc. said the 9.3% decrease in revenue was driven primarily by reduced sales in the European market amid an increasingly restrictive regulatory environment for vaping products.
Ispire Technology Inc. reported gross profit of $4.5 million and a gross margin of 16.2% for the quarter ended September 30, 2026. Gross margin was 17.0% in the year-ago period and 6.3% in the prior quarter; the company attributed the sequential recovery to the one-time inventory impairments and returns charges recorded in the fourth quarter of fiscal 2026.
Ispire Technology Inc. reported a GAAP net loss of $6.4 million, or ($0.11) per share, and Adjusted EBITDA of $136,000 for the quarter ended September 30, 2026. The net loss compared with $3.3 million, or ($0.06) per share, in the year-ago quarter, while Adjusted EBITDA compared with $0.6 million in that period and improved sequentially from an Adjusted EBITDA loss of ($2.3) million.
Ispire Technology Inc. reported total operating expenses of $10.6 million, up from $7.8 million in the first quarter of fiscal year 2026, driven primarily by non-cash credit loss expenses. Credit loss expense was $4.8 million, compared with $1.8 million in the year-ago period, and the company said the current-quarter net loss included $4.8 million of credit loss expense.
At September 30, 2026, Ispire Technology Inc. held cash of $15.6 million and working capital of $0.4 million. These represented decreases of $3.7 million in cash and $0.4 million in working capital from the fiscal year ended June 30, 2026.
Ispire Technology Inc. said it reduced net accounts receivable by approximately 80% from peak levels in fiscal 2025. The company attributed this to collections, allowances for credit losses recorded against outstanding balances, and improvements in customer credit standards and payment terms.
Ispire Technology Inc. is expanding production capabilities in Malaysia, pursuing new original equipment manufacture and original design manufacture relationships, and advancing its nicotine pouch strategy. Management also identified the company's Vapor OEM and ODM pipeline, G-Mesh technology, its 40% owned IKE Tech joint venture's age-gating platform and its nicotine pouch joint venture with Jincheng Pharma as areas of opportunity.
Ispire Technology Inc. said it believes it is close to securing a significant OEM and ODM relationship with a well-known regional brand in Southeast Asia. Steven Przybyla, President of Ispire, said the company hoped to update investors on the deal in the coming months; the source does not state that the relationship has been secured.
Ispire Technology Inc. said IKE Tech is advancing its commercialisation efforts, including the planned U.S. pilot of its IKE 2.0 age-gating platform with Charlie's Holdings. The source describes this as a planned pilot rather than a completed deployment.
Ispire Technology Inc. said it continues to focus on achieving cash-flow-positive performance while making investments in its Malaysia manufacturing facility during fiscal year 2027. Management expects cash flow to improve as the benefits of the company's new manufacturing and commercial programmes begin to scale, while its forward-looking statements note that the timing of positive cash flow is uncertain and it may occur, if at all.
Ispire Technology Inc. said it would conduct a conference call at 8 a.m. ET on Monday, November 9, 2026, followed by a question-and-answer session. A playback was stated to be available until 11:59 pm ET on Monday, November 23, 2026.